About
Leadership
Board of Directors
History
Contact Us
Portfolio
Overview
IP Estate
Publications
Investors & News
Overview
Stock Information
Press Releases
Events
Publications
Financials & Filings
Corporate Governance
Investor Resources
Contact IR
Press release
Takeda Doubles Down on Finch’s Microbiome Insights, Signing Up for A Second Project in Crohn’s Disease
Nov 13, 2019
Takeda Doubles Down on Finch’s Microbiome Insights, Signing Up for A Second Project in Crohn’s Disease
Media contact:
Gabriella Linville-Engler
[email protected]
Investor contact:
Greg Perry
[email protected]
Contact us
[email protected]
617-229-6499
75 State Street
Suite 100, Mailbox 5836
Boston MA, 02109
Policies
© 2024 Finch Therapeutics Group, Inc. All rights reserved.